Clinical Trial Update: Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial called XLPAD-TRACE evaluating a thrombin receptor antagonist intervention for claudication in perip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: North Texas Veterans Healthcare System | Conditions: Peripheral Arterial Disease | Phase 4 | Status: UNKNOWN